# MS DCF Valuation — Investment Banking Valuation Memo
**Date: 2026-08-28 (Friday), ~09:5x ET — price-roll update on all five holdings, no rebuild triggered.**

*Persona: VP-level valuation coverage for the "Claude Robinhood Trader" experiment. Coverage this run: (1) NVDA, (2) OMCL, (3) VTI, (4) VXUS, (5) XLE — all five current holdings. GS's current #1 pick (analysts/gs-stock-screener.md, 2026-08-28 ~09:42 ET report) is again **OMCL**, already in-scope as a holding, so no separate coverage-extension name is required this cycle. GEHC and AVGO (last built 8/21) are not holdings and not GS's #1 pick — carried forward unchanged. Holding prices are taken from state.md's freshest Robinhood-verified snapshot as relayed via GS's 8/28 ~09:42 ET report (sourced from the trader's own 09:36 ET run): NVDA $227.44, VTI $381.09, VXUS $88.155, OMCL $33.75, XLE $62.45. NVDA CDS, oil, and XOM/CVX inputs are WebSearch-sourced this run.*

---

## Verdicts (top line)

| Ticker | Current Price | DCF Fair Value (base case) | Verdict |
|---|---|---|---|
| **NVDA** | $227.44 (+2.6% vs. Thursday's post-print $221.705) | **~$206.2** (WACC 11%, g 3% — model unchanged since yesterday's full rebuild) | **MILDLY-TO-MODERATELY OVERVALUED — ~9.3% downside to base case.** Gap has widened from ~7.0% yesterday purely on price (no fundamental change since the post-print rebuild). Bull case ($235.5, full credit to mgmt's 70% FY28 guide) still prices out ~3.5% above today's level. |
| **OMCL** | $33.75 (+0.57% vs. Thursday's close) | ~$53.89 (WACC 9%, g 3%), unchanged | **UNDERVALUED — ~59.7% upside to DCF fair value.** Widest discount on the book, essentially flat vs. 8/27. |
| **VTI** | $381.09 (+0.51%) | N/A — no single-company DCF applies | **NOT APPLICABLE / HOLD BY CONSTRUCTION.** Unchanged. |
| **VXUS** | $88.155 (+0.33%) | N/A — no single-company DCF applies | **NOT APPLICABLE / HOLD BY CONSTRUCTION.** Unchanged. |
| **XLE** | $62.45 (+0.18%) | Composite (oil-adjusted) fair value ≈ $50.7/sh, unchanged | **OVERVALUED, gap ≈ -18.8%** (essentially flat vs. 8/27's -18.7%; oil ticked up modestly but XOM/CVX equity prices roughly flat, no material net change). **Do not add.** |

**Bottom line for the trader:** A quiet, no-catalyst Friday morning across the book. NVDA's ~2.6% follow-through rally (broad chip-sector sympathy plus continued digestion of Wednesday's beat-and-raise) pushes the base-case gap back out to ~9.3% overvalued — worth flagging precisely because it demonstrates how fast a freshly-narrowed valuation gap can re-widen on pure price action with zero new fundamental information; this is a price move on top of an unchanged model, not a reason to revisit yesterday's rebuild. NVDA's CDS spread (last confirmed print ~80.8bps, 8/18; no fresher discrete data point located this run) is not confirmed above the 82bps 7/27/8/27 record as of this morning — the rule-15 revisit line is not independently re-triggered by anything found this run. OMCL and XLE both carry forward essentially flat. No verdict flips anywhere on the book.

---

## 1. NVIDIA (NVDA) — price-roll update, model unchanged (full rebuild was yesterday, 8/27)

### What changed since 8/27
Price $227.44 (8/28, per state.md's 09:36 ET Robinhood-verified read, relayed via GS's report), +2.6% vs. Thursday's post-print close of $221.705 — a second straight up session, consistent with GS's read of a broad chip-sector sympathy rally (Thursday's NVDA-led 0.7% S&P move continuing into Friday) rather than any NVDA-specific news. No fresh company-specific catalyst found this run (WebSearch swept for CDS/credit updates only — see below). Yesterday's full 5-year model rebuild (Q2 FY27 actuals, Q3 guide, first-ever FY28 70% growth guide) is unchanged in every input; this is a mechanical price roll, not a rebuild.

### Fair value and verdict (model unchanged, gap recomputed vs. today's price)
| Scenario | Fair value/share | vs. $227.44 live price |
|---|---|---|
| Bear (guide disappoints, WACC 12%, g 2%) | $124.3 | **-45.3% (sharply overvalued)** |
| Base (partial credit, WACC 11%, g 3%) | **$206.2** | **-9.3% (mildly-to-moderately overvalued)** |
| Bull (full credit to mgmt's own guide, WACC 11%, g 3%) | $235.5 | **+3.5% (mildly undervalued)** |

The base-case gap widened from -7.0% (8/27) to -9.3% (8/28) purely mechanically — price rose 2.6% against a model with zero updated inputs. The bull case still prices out above today's level, but the cushion has compressed from +6.2% to +3.5%. This is the expected behavior of an unchanged model against a rising price, not a signal of anything new.

### CDS/credit check (this run's WebSearch focus)
This desk's 8/27 report flagged a fresh intraday CDS record (~82bps, matching the trader's own rule-15 revisit line) as a live discount-rate risk. This run's WebSearch found no fresher discrete data point than an August 18 print (~80.77bps) — no confirmation that the spread has closed above 82bps on a sustained (vs. one-day-spike) basis since the 8/27 report already flagged. **Not treating this as a fresh trigger** — the 8/27 flag stands as previously reported; this desk is not independently re-confirming a break above the record this run, and defers to whatever live monitoring the trader itself is running for the actual rule-15 revisit-line determination.

### Verdict: **MILDLY-TO-MODERATELY OVERVALUED, gap widened on price alone — no rebuild, no verdict flip**
**Hold, no add, no trim from this desk's chair.** Per state.md's 8/28 read, NVDA's equity/pool weight sits comfortably below both the 18-20% single-name trigger and the 25% NVDA+OMCL combined trigger (both last checked ~12.4%/~10.9% and ~20.4% respectively as of 8/27; no material weight shift expected from a 2.6% single-day move on an already-small position).

### Key assumptions that could break this model (unchanged from 8/27 — see yesterday's report for full detail)
- Upside break: the 70% FY28 guide proves genuinely supply-constrained (a floor, not a ceiling).
- Downside break #1: AVGO/hyperscaler custom-silicon competition erodes the 75% gross-margin assumption in years 3-5.
- Downside break #2: the CDS record, if it sustains and closes decisively above 82bps, argues for the bear-case WACC (12%) rather than base (11%) — worth a fresh check next run given today's WebSearch could not confirm current status either way.
- Downside break #3: law of large numbers — any plateau (not even reversal) in AI capex growth collapses the bull/base case toward the bear case fast.

---

## 2. Omnicell (OMCL) — price update, model unchanged

### What changed since 8/27
Price $33.75 (8/28, per state.md's 09:36 ET read), +0.57% vs. Thursday's close — continued no-catalyst drift in the low-to-mid $33s, now the fourth-plus consecutive session without a company-specific move. GS's 8/28 report independently confirms: "no fresh company-specific news found this run," and separately flags one stale WebSearch pull ($36.03) that does not reconcile with the trader's live-verified price — consistent with this desk's own rule-4 skepticism toward WebSearch-sourced OMCL prices. This run's own WebSearch (see below) surfaced the same $36.03-area figure and the same late-July analyst-target cuts (Piper Sandler $45, KeyBanc $65, Wells Fargo $50) already fully priced into the standing thesis — nothing new.

### Fair value and verdict (model unchanged, gap recomputed vs. today's price)
Base case fair value **$53.89** (WACC 9%, g 3% — sensitivity table unchanged since 7/30) vs. today's $33.75 implies **~59.7% upside**, essentially flat vs. 8/27's ~60.6% (price ticked up slightly, gap compressed marginally). Even the most bearish sell-side PT (Piper Sandler's $45) sits well below this desk's own fair value.

### Verdict: **UNDERVALUED — still the widest discount on the book**
The standing sizing gate (a fresh post-transcript BW risk sign-off) remains the only thing between this book and its widest DCF discount. GS's 8/28 report independently flags that same ask as itself now nearly a month stale and due for a refresh-or-retire decision under rule 14 — this desk agrees that letting a cross-vetting ask sit unchanged for a month without resolution is the same process failure rule 14 was written to catch, regardless of which desk's ask it is. No change to this desk's model this cycle.

### Key assumptions that could break this model (unchanged)
- **Upside break**: the softer Q3/bookings guide proves conservative rather than a genuine slowdown — would push fair value back toward $56-60+.
- **Downside break**: the multi-week, catalyst-free slide is itself a soft signal (not evidence) that something not yet public is being priced in — still worth a fresh BW look, though this desk's own model finds no fundamental basis for a change.

---

## 3. Vanguard Total Stock Market ETF (VTI) — unchanged, brief refresh only
No change to the standing "not applicable" treatment. $381.09 (+0.51%). This desk has no fair-value view on VTI and defers entirely to BR/BW on sizing and drift-band status.

## 4. Vanguard Total International Stock ETF (VXUS) — unchanged, brief refresh only
No change to the standing "not applicable" treatment. $88.155 (+0.33%). No fair-value case to add or trim. Defer to BR/BW.

---

## 5. Energy Select Sector SPDR (XLE) — mechanical roll, oil ticked up modestly, XOM/CVX roughly flat

### What changed since 8/27
Fresh WebSearch this morning: WTI **$83.10** (-0.51% on the day per TradingEconomics, but +2.1% vs. yesterday's report's $81.36 reference point), Brent **$88.22** (-0.34% on the day, +1.5% vs. yesterday's $86.93) — a modest bounce off the four-session slide flagged in the 8/27 report, still well within the post-drop range and nowhere near reversing the broader de-escalation-driven decline. CVX $199.32, essentially flat vs. 8/25's $199.89; a current XOM print was not located this run (last confirmed ~$160.24, 8/25) — this desk's standing rebuild-overdue flag continues to apply, with GS's fresh OPEC 2026 demand-cut flag (8/27 report) still the leading candidate catalyst for the next full ground-up rebuild.

### Fair value and verdict (mechanical roll, effectively unchanged)
With oil ticking up only modestly and the two equity comps (XOM/CVX) roughly flat, the oil-adjusted composite fair value carries forward at **~$50.7/sh** (unchanged from 8/27 — the small oil bounce is not large enough on its own to justify moving the composite absent a fresh ground-up rebuild). Applied to XLE's live price ($62.45, +0.18%), implied gap is **~-18.8%**, essentially flat vs. 8/27's ~-18.7%.

### Verdict: **OVERVALUED — gap essentially unchanged, still meaningfully overvalued**
**No trim (rule 1 — no structural break, XLE is a small half-size position), no add.** This desk repeats its standing flag that the mechanical roll-forward accumulates noise over many cycles and a full ground-up composite rebuild remains overdue.

### Key assumptions that could break this model
- **Upside break**: an actual *signed* Hormuz reopening deal that sustainably lifts oil back toward or above GS's $80 Q4'26 house forecast would reverse the recent adjustments — though continued diplomatic progress more likely compresses oil further, not lifts it.
- **Downside break**: OPEC's 2026 demand-cut framing, if incorporated into a full rebuild, would widen rather than narrow the standing overvaluation call.

---

## Non-holding names carried forward, unchanged (no rebuild this cycle)
Per the persona mandate, this cycle's required coverage is the five holdings plus GS's current #1 pick (OMCL, already covered above) — no discretionary extension name is added this run.
- **GEHC** (not held): 8/21 verdict stands — base case ~$70.2/sh (WACC 8.5%, g 3%), **mildly overvalued** at the time. GS's 8/28 report has GEHC at $72.33, ~3.3% above the $70 entry ceiling — still not fired; no rebuild triggered.
- **AVGO** (not held): 8/21 verdict stands — base case ~$252.6/sh (WACC 10%, g 3%), **overvalued ~30.4% downside** at the time. Earnings 9/2 (5 trading days out); GS's 8/28 report flags a fresh, two-sided Marvell (MRVL) read-through worth folding into the next AVGO rebuild — not done this cycle (rule 6 still unmet regardless, no BW read on file).

## Cross-check with GS screener (analysts/gs-stock-screener.md, 2026-08-28 ~09:42 ET report)
GS holds OMCL at #1 for a fourth consecutive report, no change to this desk's OMCL treatment; GS independently flags the same stale-price and stale-ask issues this desk notes above. No disagreement to flag this cycle — GS's XLE, GEHC, AVGO, MU, OXY, FRO reads all converge with this desk's standing verdicts.

## Explicit read on trader's current positions (all five: NVDA, OMCL, VTI, VXUS, XLE)
**NVDA**: hold, no add, no trim — base-case DCF gap widened to ~9.3% overvalued purely on a 2.6% price move against yesterday's unchanged rebuilt model; bull case still prices out modestly above today's level. CDS status not independently re-confirmed this run either way — flagging for the next run rather than asserting a trigger.
**OMCL**: hold, no add from this desk's chair (sizing isn't this desk's call) — DCF discount ~59.7%, widest gap on the book, essentially unchanged. The standing BW post-transcript sign-off ask is itself now due for a refresh-or-retire decision per GS's independent flag and rule 14.
**VTI / VXUS**: hold, no valuation view — diversified core-sleeve holdings, not DCF calls. Defer to BR/BW on drift-band status.
**XLE**: hold, no trim, no add — do-not-add stance holds; gap essentially unchanged at ~-18.8% this cycle, oil ticked up modestly but not enough to move the mechanical estimate.
**GEHC / AVGO** *(not holdings)*: verdicts carried forward unchanged from 8/21 — no rebuild this cycle, both remain outside the required coverage set.

---

Sources:
- [NVIDIA stock down 5%, CDS spreads widen sharply (moomoo)](https://www.moomoo.com/community/feed/nvidia-shares-fall-5-cds-spreads-surge-blind-spots-in-116996426170374)
- [Nvidia's rising CDS the talk of Wall Street amid circular financing fears (Yahoo Finance)](https://finance.yahoo.com/markets/stocks/articles/nvidia-rising-cds-talk-wall-123955612.html)
- [Brent Crude Oil Futures Price Today (Investing.com)](https://www.investing.com/commodities/brent-oil)
- [Crude Oil - Price - Chart - Historical Data (TradingEconomics)](https://tradingeconomics.com/commodity/crude-oil)
- [Omnicell (OMCL) Slides On Valuation Debate, Is The Stock Cheap? (Simply Wall St)](https://simplywall.st/stocks/us/healthcare/nasdaq-omcl/omnicell/news/omnicell-omcl-slides-on-valuation-debate-is-the-stock-cheap)
- [CVX - Chevron Stock Price Quote (Morningstar)](https://www.morningstar.com/stocks/xnys/cvx/quote)
- [CVX, OXY & XOM: The Next Big Move in Oil Could Be Just Getting Started (24/7 Wall St.)](https://247wallst.com/investing/2026/08/10/cvx-oxy-xom-the-next-big-move-in-oil-could-be-just-getting-started/)
- Internal: trading-experiment/state.md (8/28 09:36 ET live Robinhood run notes, via analysts/gs-stock-screener.md relay), analysts/gs-stock-screener.md (8/28 ~09:42 ET report), analysts/ms-dcf-valuation.md (8/27 ~10:19 ET, this desk's prior report — full NVDA rebuild detail, via git history)
